Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science

BACKGROUND: Contemporary therapies for metastatic castration-resistant prostate cancer (mCRPC) have shown survival improvements, which do not account for patient experience and health-related quality of life (HRQoL). METHODS: This literature review included a search of MEDLINE for randomized clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Nussbaum, N, George, D J, Abernethy, A P, Dolan, C M, Oestreicher, N, Flanders, S, Dorff, T B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868871/
https://www.ncbi.nlm.nih.gov/pubmed/26832363
http://dx.doi.org/10.1038/pcan.2015.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868871/
https://www.ncbi.nlm.nih.gov/pubmed/26832363
http://dx.doi.org/10.1038/pcan.2015.42

Ejemplares similares